Via Wisbusiness.com The number for overall economic output activity from direct, indirect and induced sources is even higher -- nearly $48 billion. The report, compiled by Baker Tilly, was commissioned by BioForward. It updates numbers from a 2015 report on the same subject, which relied on information...
UW-Madison's Forward BIO Institute has been awarded $5 million from the National Institutes of Health for tissue manufacturing. The grant was announced yesterday at the Biohealth Summit by Professor Bill Murphy, the institute's director. "This is a unique public-private collaboration that's committed to advancing the global biomanufacturing...
The recently announced Forward BIOLABS will serve as a landing place for startups, many of which will come out of UW-Madison research. That’s according to co-founder Jessica Martin Eckerly. She says the nonprofit’s goal is to establish a fully equipped life sciences laboratory for early-stage companies,...
Arrowhead Pharmaceuticals says it has reached a licensing and collaboration agreement with Janssen Pharmaceuticals that will bring the company $250 million to start and ultimately could be worth as much as $3.7 billion. Janssen will get the worldwide exclusive license for ARO-HBV, a drug that treats...
An eight-year quest to find the cause of a disease has apparently ended now that scientists at UW-Madison have identified the mutations that produce a form of myelofibrosis, a rare genetic blood disorder. Mutations in a protein that controls the production of blood platelets appear to...
Ten winners winners were honored from the thirty-three finalists and more than 350 nominees during the 2018 Wisconsin Innovation Awards at the Wisconsin Union Terrace. The ceremony, emceed by local entrepreneur and Filament Games Vice President of Sales, Jennifer Javornik recognized the state’s most innovative products...
Biochemistry assistant professor Srivatsan “Vatsan” Raman has received a Director's New Innovator Award from the National Institutes of Health (NIH). The $2.2 million-grants fund high-risk, high-reward research performed by early stage investigators. Compared to traditional NIH grants, the New Innovator Award supports “unusually creative early stage investigators” whose research can have...
An influenza vaccine developed by FluGen, of Madison, is being tested on children and teenagers in a clinical trial that’s being subsidized by a division of the National Institutes of Health. The test began in August, according to a statement last week by the National Institute...
Discovery to Product, which supports and mentors faculty, staff and student innovators and entrepreneurs on campus, is offering a new program called Innovation to Market. The fall I2M program builds on the success of D2P’s Igniter program cohorts that helped start 19 companies over the...
By Jeff Barrett CEO, Barrett Digital How Madison's talent base makes it a major player for attracting companies. It took me 33 years to make it to Madison, Wisconsin, and I grew up a state away in Michigan. To be fair there is a giant lake between us....
The All of Us Research Program reached an important milestone, enrolling 100,000 participants nationwide in its historic journey to positively impact the future of health research and treatment for generations. The All of Us Research Program at the University of Wisconsin-Madison, which is part of a...
A new study from NeuroPointDX of Madison and University of California researchers shows biochemical markers could allow for earlier identification of autism spectrum disorder. Lead author David Amaral says this discovery could also lead to avenues for therapeutic intervention. NeuroPointDX is a division of Stemina Biomarker Discovery,...